Search results
Ionis (IONS), Biogen Down on Ending Development of ALS Drug
Zacks via Yahoo Finance· 4 hours agoShares of Ionis Pharmaceuticals IONS and Biogen BIIB lost at least 2% in market cap on Thursday...
Ionis (IONS) Q2 Loss Narrows Y/Y, Sales Surpass Estimates
Zacks via Yahoo Finance· 9 months agoIonis Pharmaceuticals IONS reported a loss of 60 cents per share for second-quarter 2023, which was...
Ionis (IONS) Q1 Loss Narrower Than Expected, Sales Miss
Zacks via Yahoo Finance· 1 week agoIonis Pharmaceuticals IONS reported a loss of 98 cents per share for first-quarter 2024, which was...
Biogen Inc. (BIIB) Down 2.3% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 1 year agoA month has gone by since the last earnings report for Biogen Inc. (BIIB). Shares have lost about...
Why Is Biogen Inc. (BIIB) Up 2.6% Since Last Earnings Report?
Zacks via Yahoo Finance· 2 months agoIt has been about a month since the last earnings report for Biogen Inc. (BIIB). Shares have added...
Biogen Is Suffering From Doubts About the Future
GuruFocus.com via Yahoo Finance· 1 month agoBiogen Inc. (NASDAQ:BIIB) is an American biopharmaceutical company specializing in the development and commercialization of biosimilars and medicines...
Ionis (IONS) Q3 Earnings & Sales Beat Estimates, Stock Up
Zacks via Yahoo Finance· 2 years agoIonis Pharmaceuticals IONS reported a loss of 33 cents per share in third-quarter 2022, narrower...
Biogen (BIIB) Beats on Q2 Earnings & Sales, Ups 2022 Guidance
Zacks via Yahoo Finance· 2 years agoBiogen BIIB reported second-quarter 2022 earnings per share (EPS) of $5.25, which significantly beat...
Biogen (BIIB) Beats Q4 Earnings & Sales Estimates, Stock Up
Zacks via Yahoo Finance· 1 year agoBiogen BIIB reported fourth-quarter 2022 adjusted earnings per share (EPS) of $4.05, beating the...
Will Biogen (BIIB) Beat Estimates This Earnings Season?
Zacks via Yahoo Finance· 1 year agoWe expect Biogen BIIB to beat expectations when it reports fourth-quarter and full-year 2022 results...